Country intelligence
Deals, market moves, science and policy across the platform tagged to Sweden.
Available only through a rigorous individual-licence process, with numbers slowly rising.
A specialist must apply on the patient's behalf, evidencing benefit and that other treatments are exhausted; an initial three-month prescription is reviewed before an annual licence may be granted. In 2024 the Karolinska Institute launched a national observational study on cannabis-based treatments.
Nothing tagged to Sweden yet. Tag deals, studies or articles with this country to see them here and on the map.
